Titer– tag –
-
CDMOs Overcome Multispecific Manufacturing Challenges with Continuous Bioprocessing and Catalent’s GPEx® Lightning Platform
BioSpace Unknown Overview Contract Development and Manufacturing Organizations (CDMOs) confront complex challenges in cell line development, analytical characterization, and downstream purification for multispecific molecules. To overcom... -
4basebio and Genezen Partner to Revolutionize Viral Vector Manufacturing: hpDNA Boosts AAV Titers by up to 33-fold
AllSci Overview 4basebio and Genezen have announced a strategic collaboration to integrate 4basebio's hpDNA platform into viral vector manufacturing workflows, aiming to significantly enhance efficiency. This innovative cell-free synthet... -
Bioprocess Insider Reports AI Tools Revolutionize Antibody Design, Viral Titer Measurement, and Workforce Readiness in Minutes, Optimizing Gene Therapy Manufacturing
Bioprocess Insider UK Overview Bioprocess Insider reports that AI tools are driving extensive innovations in bioprocessing, with GeneData presenting an end-to-end optimization platform and BioCurie developing real-time rAAV (recombinant ... -
4basebio and Genezen Partnership Revolutionizes Viral Vector Manufacturing: Cell-Free Synthetic DNA Reduces Costs by 30%
BioPharm International USA Overview 4basebio and viral vector CDMO Genezen announced a partnership to integrate 4basebio's cell-free hpDNA platform into Genezen's manufacturing workflow. This innovative technology enzymatically produces ... -
Bioseon Unveils Proof-Driven Operating Guides for Autonomous Biologics Manufacturing, Supporting CDMOs and Biopharma with Live Titer & CQA Control via Soft Sensors and Digital Twins
Bioseon Unknown Overview Bioseon has released 'Proof-Driven Operating Guides' for autonomous biologics manufacturing. These guides focus on live titer and critical quality attribute (CQA) control utilizing soft sensors, Process Analytica... -
AI Drives Bioprocess Optimization, Enhancing Titer, Rate, and Yield (TRY) in Pharmaceutical Manufacturing
Corvic AI (Facebook) Global Overview Artificial intelligence (AI) is emerging as a pivotal technology transforming pharmaceutical manufacturing by dramatically boosting efficiency and quality in bioprocess development. Machine learning m... -
Chemically Defined, Serum-Free Media Innovations Drive Market Expansion: AuctuCel Launches AI-Powered Medium, Gibco Achieves High CHO Cell Titer
Media City Scientific Singapore Overview Innovations in serum-free and chemically defined media are rapidly advancing, eliminating animal-derived components and boosting reproducibility in cell culture. Qkine launched FRS™ Pioneer, while... -
New Manufacturing-Scale Cell Culture Media Preparation Guide Optimizes Quality and Efficiency with WFI Temperature Control (15-25°C) and Filtration Sizing (0.5-2m²/1000L)
BioProcess Tools Global Overview A new guideline for manufacturing-scale cell culture media preparation emphasizes that media quality directly impacts cell growth, viable cell density, and product titer. Achieving pharmaceutical-grade pr... -
Gyros Protein Technologies Streamlines Biotherapeutic Impurity Testing with Automated Immunoassay Platform: Enhancing Reproducibility and Throughput
Bioprocess International (via Gyros Protein Technologies webcast summary) USA Overview Gyros Protein Technologies is addressing impurity testing challenges in biotherapeutic development with its Gyrolab automated immunoassay platform. Th... -
CDMO Signal Ranks Top FDA & GMP-Compliant Lentiviral Vector Manufacturing CDMOs
CDMO Signal Global Overview CDMO Signal has released a ranking of top Lentiviral Vector (LVV) CDMOs, crucial for ex vivo gene therapy, based on FDA inspection history, GMP certification, clinical program activity, and capacity. LVVs are ...
12